Background illustration for clinical trials search

Paid Clinical Trials Cincinnati

Discover 1,168 paid clinical trials in Cincinnati, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis Patients

for
Tuberculosis, Pulmonary
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 18+

Code: NCT07077213

Recruiting
Active & Responsive

EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)

for
PIK3CA-related Overgrowth Spectrum (PROS)
Location: Cincinnati OH, Columbus OH, Pittsburgh PA, St Louis MO,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 2 - 70+

Code: NCT06997588

Phase 2, Recruiting
Active & Responsive

Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis

for
Hemophilia A
Location: Cincinnati OH, Indianapolis IN, Detroit MI, Chicago IL,
Sponsor: Wayne State University

Sex: All

Age: 6 - 19

Code: NCT05022459

Recruiting
Active & Responsive

Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)

for
Pompe Disease
Location: Cincinnati OH, Pittsburgh PA, St Louis MO, Atlanta GA,
Sponsor: Shionogi

Sex: All

Age: 18+

Code: NCT07123155

Phase 2, Recruiting
Active & Responsive

Allogeneic Hematopoietic Cell Transplantation for Refractory Systemic Juvenile Idiopathic Arthritis.

for
Refractory Systemic Juvenile Idiopathic Arthritis,
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 0 - 35

Code: NCT07845942

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas

for
Neurofibromatosis 1, Plexiform Neurofibroma
Location: Cincinnati OH, Indianapolis IN, Washington D.C. DC,
Sponsor: Girish Dhall, MD

Sex: All

Age: 16+

Code: NCT06502171

Phase 1, Recruiting
Active & Responsive

A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077)

for
Cytomegalovirus Prophylaxis
Location: Cincinnati OH, Ann Arbor MI, Chicago IL, Pittsburgh PA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 17

Code: NCT07199465

Phase 1, Recruiting
Active & Responsive

Efficacy of Tezepelumab in Peanut Oral Immunotherapy

for
Peanut Allergy
Location: Cincinnati OH, Chapel Hill NC, Baltimore MD,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 12 - 55

Code: NCT07015996

Phase 2, Recruiting
Active & Responsive

A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease

for
Fabry Disease
Location: Cincinnati OH, Atlanta GA, Fairfax VA, Iowa City IA,
Sponsor: Chiesi Farmaceutici S.p.A.

Sex: All

Age: 2 - 17

Code: NCT06328608

Phase 2, Phase 3, Recruiting
Active & Responsive

Clinical Course Of Disease In Participants With FA-CM

for
Friedreich Ataxia, Cardiomyopathy
Location: Cincinnati OH, Indianapolis IN, St Louis MO,
Sponsor: Lexeo Therapeutics

Sex: All

Age: 6+

Code: NCT06865482

Recruiting
Active & Responsive

Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular Dystrophy

for
LAMA2-MD \(Merosin Deficient Congenital Muscular Dystrophy, MDC1A\),
Location: Cincinnati OH, Columbus OH, Chicago IL, Pittsburgh PA,
Sponsor: Nationwide Children's Hospital

Sex: All

Age: 0 - 5

Code: NCT06503367

Recruiting
Active & Responsive

High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients

for
Immunization; Infection, Transplantation Infection, Influenza
Location: Cincinnati OH, Indianapolis IN, Nashville TN,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 3 - 17

Code: NCT05947071

Phase 2, Recruiting
Active & Responsive

Fontan Udenafil Exercise Longitudinal Assessment Trial - 2

for
Single Ventricle Heart Disease
Location: Cincinnati OH, Columbus OH, Ann Arbor MI, Cleveland OH,
Sponsor: Mezzion Pharma Co. Ltd

Sex: All

Age: 12 - 18

Code: NCT05918211

Phase 3, Recruiting
Active & Responsive

Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma

for
Pleuropulmonary Blastoma
Location: Cincinnati OH, Dayton OH, Louisville KY,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT06647953

Phase 3, Recruiting
Active & Responsive

Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy

for
Acute Myeloid Leukemia
Location: Cincinnati OH, Madison WI, Memphis TN, Hershey PA,
Sponsor: Norman J. Lacayo

Sex: All

Age: 0 - 21

Code: NCT05101551

Phase 1, Recruiting
Active & Responsive

Pediatric Post-Approval Registry

for
Obstructive Sleep Apnea
Location: Cincinnati OH, Sewickley PA, Durham NC, Norfolk VA,
Sponsor: Inspire Medical Systems, Inc.

Sex: All

Age: 18 - 21

Code: NCT04457154

Recruiting
Active & Responsive

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

for
Parenteral Nutrition Associated Liver Disease (PNALD),
Location: Cincinnati OH, Nashville TN, Chicago IL, Boston MA,
Sponsor: Fresenius Kabi

Sex: All

Age: 0 - 17

Code: NCT06274788

Recruiting
Active & Responsive

A Prospective Analysis of Long-Term Clinical Outcomes and 3D Spine Growth in Anterior Vertebral Body Tethering

for
Scoliosis Idiopathic
Location: Cincinnati OH, Nashville TN, Chicago IL, St Louis MO,
Sponsor: Pediatric Spine Foundation

Sex: All

Age: 0 - 18

Code: NCT04914507

Recruiting
Active & Responsive

A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)

for
PIK3CA-Related Overgrowth Spectrum (PROS),
Location: Cincinnati OH, Indianapolis IN, Cleveland OH,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 2+

Code: NCT06789913

Phase 2, Recruiting
Active & Responsive

OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages

for
Eosinophilic Gastrointestinal Disorders (EGIDs),
Location: Cincinnati OH, Nashville TN, Chicago IL, Chapel Hill NC,
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 3+

Code: NCT02523118

Recruiting